Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-008244
Filing Date
2011-02-08
Accepted
2011-02-08 16:33:18
Documents
2
Period of Report
2011-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd299932.html 3  
1 FORM 3 rrd299932.xml 3 5760
2 POWER OF ATTORNEY rrd268832_303649.htm EX-24.1 3245
  Complete submission text file 0001181431-11-008244.txt   10917
Mailing Address NABI PHARMACEUTICALS 5800 PARK OF COMMERCE BLVD N.W. BOCA RATON FL 33487
Business Address
SMITH MARK L (Reporting) CIK: 0001206467 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35073 | Film No.: 11583041

Mailing Address 345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD CO 80112
Business Address 345 INVERNESS DRIVE SOUTH, BUILDING C Suite 310 ENGLEWOOD CO 80112 303-858-8358
Gevo, Inc. (Issuer) CIK: 0001392380 (see all company filings)

EIN.: 870747704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2860 Industrial Organic Chemicals